|
1-20 (of 531) related articles
Items per page
| |
|
The surprising world of public policy
HEADNOTE A closer look at ALLHAT and Sarbanes-Oxley uncovers the sometimes unpredictable ways in which mega-companies respond to ... (PERIODICAL ARTICLE)
Statins decrease dementia risk. (Pharmacology
Update).
In a recent study from Halifax, NS, Canada, older persons who were taking lipid-lowering medication (i.e., statins) were ... (PERIODICAL ARTICLE)
Study shows it's not the price, it's the volume of use that drives drug...
An analysis of the underlying drivers of drug spending shows that growing clinical use and population are far ... (PERIODICAL ARTICLE)
A pioneer in antibiotics seeks profits elsewhere
Eli Lilly and Co. has a rich history in antibiotics. More than a half century ago, it was ... (PERIODICAL ARTICLE)
C-reative protein: From acute phase reactant to
cardiovascular disease...
The statistics are startling. Half of all myocardial infarctions occur in patients with normal plasma lipid levels. (1) ... (PERIODICAL ARTICLE)
A bitter pill to swallow: Analysts predict pharmaceutical industry headed...
While the world's attention is focused on the mortgage industry, another major U.S. industry is facing troubles of ... (PERIODICAL ARTICLE)
Abbott, AZ team up to promote Crestor
SEEKING TO increase its share of voice without beefing up its sales force, AstraZeneca is partnering with Abbott ... (PERIODICAL ARTICLE)
Ignorance Is the Remedy du Jour
TOO MANY contact center managers are measuring and addressing the wrong problems. It's the equivalent of a doctor ... (PERIODICAL ARTICLE)
TV spend competes with 'demand'
HEADNOTE With fewer big, mass-market brands and pharmaceutical companies seeking cost savings all around, will video-on-demand (VOD) and ... (PERIODICAL ARTICLE)
Would you like a disclaimer with your meal?
Had a juicy restaurant steak recently? Tell me if this exchange sounds familiar. Customer. "I'd like the 12-ounce ... (PERIODICAL ARTICLE)
Surge Worldwide Healthcare Communications
HEADNOTE Corbett Accel unit lives up to its name through "substantial" growth Double-digit growth, an expanding staff and ... (PERIODICAL ARTICLE)
Big Problems for Big Pharma
Most people have seen the television commercials featuring the dapper, middle-aged developer of die artificial heart, Dr. Robert ... (PERIODICAL ARTICLE)
Report: $1B spent on 10 prescription drugs Upstate
Upstate New Yorkers are spending a lot of money on prescription drugs, according to a new report from ... (PERIODICAL ARTICLE)
DIRECT MARKETING: Update
Harte-Hanks has announced plans to close a New Jersey office, one of its 30 company locations nationwide. Jobs ... (PERIODICAL ARTICLE)
PR REPORT: TRUST & CREDIBILITY
HEADNOTE Reversing pharma's ragged reputation is no easy task. But good intentions abound. Ben Comer reports on AstraZeneca's ... (PERIODICAL ARTICLE)
DTC has its day under the spotlights
THE HEAD OF a powerful congressional subcommittee called for tougher restrictions on DTC television advertising for prescription drugs. (PERIODICAL ARTICLE)
Do quick approvals mean risky drugs?
THE FDA SAYS it has found at least two fundamental problems with data in a Harvard study, found ... (PERIODICAL ARTICLE)
Pfizer Invests $3M in Startup To Advance Stem Cell Therapy
In a rare move for Big Pharma, Pfizer Inc. said last week that it would invest an initial ... (PERIODICAL ARTICLE)
Dr. Jarvik doesn't row.
DR. ROBERT JARVIK doesn't row. The spokesperson for Pfizer's cholesterol-lowering medication Lipitor also isn't a cardiologist, nor is ... (PERIODICAL ARTICLE)
Antidote
IMAGE ILLUSTRATION 1 Even if I had another topic planned, how could I not write this month about ... (PERIODICAL ARTICLE) | |
|
1-20 (of 531) related articles
Items per page
1-20 (of 531) related articles
|